The primary objective of this study is to characterize the real-world outcomes of spinal cord stimulation (SCS) therapy as an aid in the management of chronic intractable pain of the trunk, including unilateral or bilateral pain associated with the following: failed back surgery syndrome, intractable low back pain using the Boston Scientific (BSC) PRECISION Spinal Cord Stimulator System with MultiWave Technology.
The purpose of this study is to characterize the real-world outcomes of spinal cord stimulation (SCS) therapy as an aid in the management of chronic intractable pain of the trunk, including unilateral or bilateral pain associated with the following: failed back surgery syndrome, intractable low back pain using the Boston Scientific (BSC) PRECISION Spinal Cord Stimulator System with MultiWave Technology.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
73
Boston Scientific (BSC) PRECISION SCS System with MultiWave Technology
Schreiber Klinik
München, Germany
Azienda Ospedale Monaldi
Naples, Italy
Ziekenhuis Rijnstate
Velp, Netherlands
Southmead Hospital Bristol
Bristol, United Kingdom
St. Bartholomews Hospital
Percentage of Low Back Pain Responders
Percentage of low back pain responders at 3 months post-activation with no increase in opioids from Baseline to 3 months post-activation
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
London, United Kingdom